Volume : 09, Issue : 10, October – 2022

Title:

61.DESIGN AND DEVELOPMENT OF FLOATING MICROSPHERES OF OFLOXACIN
‬

Authors :

Sikil ghosi, Sonu rajpoot, Shubham raj, Shivraj noriya, sikesh shah, Dr Jagdish rathi, Rahul Sharma, Dr. Anjita singh

Abstract :

In the present study design and development of floating microspheres of ofloxacin. During the Preformulation studies it is found that the organoleptic properties of Ofloxacin comply as reported. Pale yellow, bitter, odorless, amorphous powder of ofloxacin was soluble in water, 0.1N HCl and Phosphate buffer (pH 6.8) and freely soluble in ethanol and methanol. Melting point was observed at 1560C and λmax at 296nm. Standard calibration curve was prepared using concentration range 5- 25 ug/ml and linearity equation as y = 0.032x – 0.003 with R2 = 0.998. Partition coefficient was found 0.989. Five different formulations were prepared by o/w emulsion solvent evaporation method using different concentration of Ethyl Cellulose EC) and fixed amount (100mg) of ofloxacin and tween-80 (1%). Evaluation of prepared floating microsphere were found yield between 91.69 to 95.43%, mean particle size between 463 to 676 µm and encapsulation efficiency between 78.6 to 98.2%. On the basis of various parameter of evaluation of floating microspheres formulations, F-4 has greater yield 95.43 % but its encapsulation efficiency was lower 74.6. F-1, F-2, F-4 and F-5 were possessed poor mircomeritic properties e.g. Carr’s Index 39.65, 37.65, 29.31 and 30.44% respectively, Hausner’s ratio 1.657, 1.604, 1.415 and 1438 respectively and angle of repose (θ) 31, 35, 28 and 29 respectively that indicates irregular shape, improper size distribution and poor to very poor flow properties of the prepared microsphere. Hence, all formulations except F-3 were not suitable for further investigation. F-3 microsphere batch possessed yield (91.69%), particle size (676 µm), encapsulating efficiency (98.2), Carr’s Index (5.08%), Hausener’s ratio (1.054) and also drug release was 97.913 %. Stability studies for 30 days was performed on three different temperatures (4, 25 & 45oC) and found that no significant variation in % drug release of optimized floating microspheres batch F-3 during whole study.
KEYWORDS: Residence time, Sustained release, therapy, drug release, bioavailability

Cite This Article:

References:

1. Chien YW. Concepts and system design for rate controlled drug delivery in novel drug delivery system. 2nd ed., New York: Marcel dekker Inc. 1992; 50:1-42.
2. Chiao CS, Robinson JR. Sustained release drug delivery system. In: Longer MA, Robinson JR (editors). Remington: The science and practice of industrial pharmacy. 19th edn. Eastern Pennsylvania. Mack Publication Company 1995; 2: 1660-75.
3. Tortora GJ, Grabowski SR. Principles of Anatomy and Physiology. 10th edn., New York: John Wiley and Sons 2002; 866-73.
4. Ross, Wilson. Anatomy and Physiology in health and illness. 9th edn., London: Churchill livingstone 1996; 294-8.
5. Brahmankar DM, Jaiswal SB. Biopharmaceutivs and pharmacokinetics a treatise. 1st ed. Vallabh Prakashan. 2002; 337.
6. Martindale. The complete drug reference. Edited by Parfitt K. 36th edn; (I):218.1.
7. The Merck Index. An encyclopedia of chemicals, drugs and biological. 13th edn: 1925.
8. Drug facts and comparisons. 50th edition. 1996:2018-19.
9. Shinde AJ, Harinath MN. Gastroretentive Drug Delivery System: An Overview 2008;6(1).
10. Gapa P, Gaba M, Garg R, Gupta GD. Floating microspheres: a review 2008; 6(5). Available from URL: http://www.pharmainfo.net/reviews/floating-microspheres-review.
11. Lalla JK. Introduction to controlled release and oral controlled drug delivery systems. The Eastern pharmacist 1991; 45:25-8.
12. Gadad AP, Naduvinamani SN, Patil MB, Dandagi PM, Manvi FM. Floating alginate beads: A novel approach to prolong gastric residence, an overview. Int J Pharma Excip 2008; 7(1):5-11.
13. R Garg, GD Gupta. Progress in Controlled Gastroretentive Delivery Systems. Trop J Pharm Res 2008; 7 (3):1055-1066.
14. MaliK K, Havaldar VD, Kulkarni AS, Dias RJ, Aloorkar NH, Floating matrix tablets of atenolol: Formulation andin-vitro evaluation. Asian J pharm 2009; 3(4):286-291.
15. Jain SK, Agrawal GP, Jain NK. Evaluation of Porous Carrier-based Floating Orlistat Microspheres for Gastric Delivery. AAPS PharmSciTech. 2006; 7(4):E1-E9.